. 2020 Oct 24;10(4):189. doi: 10.3390/jpm10040189

Table 3.

Plasma BDNF concentration in asthma patients and healthy subjects carrying different BDNF Val66Met genotypes and alleles.

BDNF Val66Met Polymorphism		Asthma Patients		Healthy Subjects
BDNF Val66Met Polymorphism		Plasma BDNF Concentration (pg/mL) Median (25%; 75%)	Statistical Analysis	Plasma BDNF Concentration (pg/mL), Median (25%; 75%)	Statistical Analysis
Genotypes	AA	0.45 (0.43; 1.24)	p = 0.52 Kruskal-Wallis test	0.56 (0.47; 0.65)	p = 0.03 Kruskal-Wallis test *
	AG	0.81 (0.52; 1.35)		0.51 (0.32; 0.73)
	GG	0.94 (0.62; 0.94)		0.68 (0.49; 1.05)
Carriers	A	0.80 (0.46; 1.34)	p = 0.39; U = 1544.00 Mann-Whitney test	0.51 (0.35; 0.70)	p = 0.008; U = 1089.00 Mann-Whitney test
	GG	0.94 (0.62; 1.20)	p = 0.39; U = 1544.00 Mann-Whitney test	0.68 (0.49; 1.05)	p = 0.008; U = 1089.00 Mann-Whitney test
	G	0.91 (0.61; 1.22)	p = 0.37; U = 120.50 Mann-Whitney test	0.59 (0.45; 0.93)	p = 0.64; U = 94.50 Mann-Whitney test
	AA	0.45 (0.43; 1.24)	p = 0.37; U = 120.50 Mann-Whitney test	0.56 (0.47; 0.65)	p = 0.64; U = 94.50 Mann-Whitney test

BDNF = Brain-derived neurotrophic factor; * AG vs. GG, p = 0.03 Dunn’s multiple comparisons test.